Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

The drug-eluting stent (DES) has become one of the most successful and important medical devices for coronary heart disease, but yet suffers from insufficient endothelial cell (EC) growth and intima repair, eventually leading to treatment failure. Although biomacromolecules such as vascular endothel...

Description complète

Détails bibliographiques
Auteurs principaux:	Jing Wang, Yunfan Xue, Jun Liu, Mi Hu, He Zhang, Kefeng Ren, Yunbing Wang, Jian Ji
Format:	Article
Langue:	English
Publié:	American Association for the Advancement of Science (AAAS) 2020-01-01
Collection:	Research
Accès en ligne:	http://dx.doi.org/10.34133/2020/1458090

Documents similaires

Ureteral stent technology: Drug-eluting stents and stent coatings
par: Luo Yang, et autres
Publié: (2015-10-01)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
par: Josep Gomez‐Lara, et autres
Publié: (2021-11-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
par: E. Y. Zagorulko, et autres
Publié: (2019-01-01)

Development of drug-eluting stent coated with PLGA nanoparticles as drug carriers
par: Yusuke Tsukada, et autres
Publié: (2013-12-01)

Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents
par: Qing Ma, et autres
Publié: (2021-12-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
par: Negar Faramarzi, et autres
Publié: (2015-10-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
par: Hang Ouyang, et autres
Publié: (2021-04-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
par: Jing Wang, et autres
Publié: (2021-12-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
par: Walid Maamoun
Publié: (2013-09-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
par: А. Н. Кудряшов, et autres
Publié: (2017-04-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
par: Paweł Gąsior, et autres
Publié: (2018-11-01)

Long-Term Clinical Outcomes of Polymer-Free Sirolimus-Eluting Stent and Polymer-Coated Sirolimus-Eluting Stent in Patients with Type 2 Diabetes
par: Yang O, et autres
Publié: (2024-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
par: Juntao Yin, et autres
Publié: (2023-01-01)

Optimized sirolimus-eluting stent by coating asymmetrically with biodegradable and cytocompatible polymers
par: Seong Min Kim, et autres
Publié: (2016-02-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
par: Yi-Xing Yang, et autres
Publié: (2020-01-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
par: I. Rykowska, et autres
Publié: (2020-10-01)

Drug Release Analysis and Optimization for Drug-Eluting Stents
par: Hongxia Li, et autres
Publié: (2013-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
par: Michał Hawranek, et autres
Publié: (2021-12-01)

Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
par: Zhu, Xiaoxiang, et autres
Publié: (2017)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
par: Masaki Hirose, et autres
Publié: (2023-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
par: Matthew G. Whitbeck, et autres
Publié: (2013-01-01)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
par: Ahmed Abdelaziz, et autres
Publié: (2024-11-01)

Everolimus-eluting coronary stents
par: Alejandro Saez, et autres
Publié: (2010-09-01)

Chiral Separation of Apremilast by Capillary Electrophoresis Using Succinyl-β-Cyclodextrin—Reversal of Enantiomer Elution Order by Cationic Capillary Coating
par: Zoltán-István Szabó, et autres
Publié: (2023-04-01)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
par: Nina Peng, et autres
Publié: (2020-01-01)

Studies of biodegradable drug-eluting tracheal stents
par: Ng, Anthony Herr Cheun
Publié: (2012)

Drug-Eluting Stents: Technical and Clinical Progress
par: Maciej Koźlik, et autres
Publié: (2023-02-01)

Drug-eluting stents: long-term safety
par: Yu A Karpov, et autres
Publié: (2009-05-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
par: Imad Sheiban, et autres
Publié: (2008-02-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
par: Sohila Refahi, et autres
Publié: (2019-03-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
par: Xiao-Fang Tang, et autres
Publié: (2018-08-01)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
par: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Publié: (2015)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
par: Jonathan Hanna, et autres
Publié: (2023-04-01)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
par: Cheng-Hsuan Tsai, et autres
Publié: (2022-06-01)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
par: Yinping Zhao, et autres
Publié: (2021-02-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
par: Ali S. Almasood, et autres
Publié: (2011-01-01)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
par: Sacharias von Koch, et autres
Publié: (2024-12-01)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
par: Fong, Timothy Ren Zhong
Publié: (2015)

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
par: Spadaccio Cristiano, et autres
Publié: (2016-01-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
par: Iraj Jafaripour, et autres
Publié: (2023-05-01)